Moolec Science SA (NASDAQ:MLEC) Short Interest Up 759.0% in April

Moolec Science SA (NASDAQ:MLEC) was the target of a large growth in short interest in April. As of April 30th, there was short interest totaling 114,402 shares, a growth of 759.0% from the April 15th total of 13,318 shares. Based on an average daily volume of 325,650 shares, the days-to-cover ratio is currently 0.4 days. Approximately 19.7% of the shares of the company are sold short.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen cut shares of Moolec Science from a “hold” rating to a “sell” rating in a research note on Sunday, April 26th.

Moolec Science Price Performance

MLEC traded up $0.39 on Tuesday, hitting $8.34. 14,541 shares of the stock were exchanged, compared to its average volume of 1,097,876. Moolec Science has a 12 month low of $3.08 and a 12 month high of $157.05. The business has a 50-day moving average of $8.58 and a two-hundred day moving average of $7.72. The firm has a market capitalization of $6.09 million, a price-to-earnings ratio of -0.25 and a beta of 0.38.

Institutional Investors Weigh In On Moolec Science

An institutional investor recently bought a new position in Moolec Science stock. Citadel Advisors LLC acquired a new position in shares of Moolec Science SA (NASDAQ:MLEC) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 36,218 shares of the company’s stock, valued at approximately $36,000. Citadel Advisors LLC owned 0.90% of Moolec Science as of its most recent SEC filing. Hedge funds and other institutional investors own 0.07% of the company’s stock.

Moolec Science Company Profile

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.